Oman vs Serbia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Oman
0.1%
in 2024
Serbia
0.1%
in 2024
Oman rank
112th
Serbia rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Oman
- Serbia
How they compare
Oman currently reports 0.1% against 0.1% in Serbia, a difference of 0.0%.
Across all 10 years both countries report, Serbia has been ahead every year.
Oman ranks 112th and Serbia ranks 112th of 215 countries.
Serbia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Oman | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Serbia |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Oman or Serbia?
- Oman, at 0.1% against 0.1% in Serbia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Oman and Serbia?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Serbia?
- 10 years are reported by both, from 2015 to 2024.
- How do Oman and Serbia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Oman ranks 112th and Serbia ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.